
Lupin Limited has informed the Exchange regarding a revised press release dated December 15, 2023, titled "Lupin Receives Approval from U.S. FDA for Allopurinol Tablets.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a revised press release dated December 15, 2023, titled "Lupin Receives Approval from U.S. FDA for Allopurinol Tablets.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin